Allergy Therapeutics plc (AIM:AGY)

Allergy Therapeutics Revenue

Allergy Therapeutics had revenue of 36.28M GBP in the half year ending December 31, 2025, with 8.07% growth. This brings the company's revenue in the last twelve months to 57.29M, up 2.94% year-over-year. In the fiscal year ending June 30, 2025, Allergy Therapeutics had annual revenue of 55.04M, down -0.28%.

• Revenue (ttm): 57.29M
• Revenue Growth: +2.94%
• P/S Ratio: 6.61
• Revenue / Employee: 98.11K
• Employees: 584
• Market Cap: 378.69M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	55.04M	-155.00K	-0.28%
Jun 30, 2024	55.20M	-4.39M	-7.36%
Jun 30, 2023	59.59M	-13.18M	-18.11%
Jun 30, 2022	72.77M	-11.56M	-13.71%
Jun 30, 2021	84.33M	6.13M	7.83%
Jun 30, 2020	78.20M	4.49M	6.09%
Jun 30, 2019	73.72M	5.37M	7.86%
Jun 30, 2018	68.35M	4.21M	6.56%
Jun 30, 2017	64.14M	15.63M	32.22%
Jun 30, 2016	48.51M	5.28M	12.21%
Jun 30, 2015	43.23M	1.28M	3.04%
Jun 30, 2014	41.96M	2.68M	6.81%
Jun 30, 2013	39.28M	-2.00M	-4.85%
Jun 30, 2012	41.28M	-272.00K	-0.65%
Jun 30, 2011	41.55M	802.00K	1.97%
Jun 30, 2010	40.75M	2.99M	7.93%
Jun 30, 2009	37.76M	6.74M	21.71%
Jun 30, 2008	31.02M	5.28M	20.51%
Jun 30, 2007	25.74M	2.18M	9.27%
Jun 30, 2006	23.56M	2.95M	14.33%
Jun 30, 2005	20.61M	-	-

Data Source: Fiscal.ai Last updated: Mar 31, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 29, 2026

Data Sources Report a data error